2026-2030年全球DNA定序市場

全球DNA定序市場預計在2025年至2030年間成長至164.21億美元，預測期間內複合年成長率為15.2%。

本報告對全球 DNA定序市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動此市場發展的因素包括精準醫療和標靶腫瘤學的進步、DNA定序相關技術的創新，以及在感染疾病監測和公共衛生領域不斷擴展的應用。

本研究客觀地結合了一手和二手訊息，包括主要行業相關人員的意見。報告內容涵蓋主要公司分析、全面的市場規模數據、區域細分分析以及供應商格局。報告還包含歷史數據和預測數據。

本研究指出，人工智慧和機器學習在藥物研發領域的應用將是未來幾年全球DNA定序市場成長的關鍵促進因素之一。此外，太空生物學和單細胞轉錄組學的進步，以及長讀長定定序在臨床和監管領域的應用擴展，預計也將產生巨大的市場需求。

目錄

第1章：執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球DNA定序市場
• 2020-2024 年最終用戶細分市場分析
• 基於解決方案的細分市場分析，2020-2024 年
• 2020-2024年基於技術的細分市場分析
• 基於應用領域的細分市場分析，2020-2024 年
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球DNA定序市場
• 地緣政治衝突的影響：全球DNA定序。

第7章：五力分析

第8章 市場區隔：依最終用戶分類

• 比較：按最終用戶
• 醫院和診所
• 製藥和生物技術公司
• 學術研究
• 臨床研究
• 市場機會：依最終用戶分類

第9章 市場區隔：依解決方案

• 比較：按解決方案
• 產品
• 服務
• 市場機會：依解決方案分類

第10章 市場區隔：依技術分類

• 比較：按技術
• 次世代定序
• 桑格定序
• 第三代定序
• 其他
• 市場機會：依技術分類

第11章 市場區隔：按應用領域

• 比較：透過應用
• 研究
• 基因組學
• 診斷
• 製藥
• 市場機會：依應用領域分類

第12章 客戶狀況

第13章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞洲
  • 日本
  • 中國
  • 印度
  • 韓國
  • 泰國
  • 新加坡
• 世界其他地區（RoW）
  • 巴西
  • 沙烏地阿拉伯
  • UAE
  • 土耳其
  • 阿根廷
  • 哥倫比亞
  • 南非
  • 以色列
• 市場機會：按地區分類

第14章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第15章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第16章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• 10X Genomics Inc.
• Agilent Technologies Inc.
• Bio Rad Laboratories Inc.
• Dante Labs Inc.
• Element Biosciences Inc.
• F. Hoffmann La Roche Ltd.
• GeneDx LLC
• GENEWIZ Inc.
• Helix OpCo LLC
• Illumina Inc.
• Oxford Nanopore Technologies
• QIAGEN NV
• Tempus AI Inc.
• Thermo Fisher Scientific Inc.
• Ultima Genomics Inc.

第17章附錄

The global dna sequencing market is forecasted to grow by USD 16421 mn during 2025-2030, accelerating at a CAGR of 15.2% during the forecast period. The report on the global dna sequencing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advancements in precision medicine and targeted oncology, technological innovations associated dna sequencing, increasing applications in infectious disease surveillance and public health.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global dna sequencing market is segmented as below:

By End-User

• Hospitals and clinics
• Pharmaceutical and biotechnology companies
• Academic research
• Clinical research

By Solution

• Product
• Services

By Technology

• Next generation sequencing
• Sanger sequencing
• Third generation sequencing
• Others

By Application

• Research
• Genomics
• Diagnostics
• Medicine

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the integration of ai and ml for drug discovery as one of the prime reasons driving the global dna sequencing market growth during the next few years. Also, advancements in spatial biology and single-cell transcriptomics and expansion of long-read sequencing in clinical and regulatory settings will lead to sizable demand in the market.

The report on the global dna sequencing market covers the following areas:

• Global dna sequencing market sizing
• Global dna sequencing market forecast
• Global dna sequencing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global dna sequencing market vendors that include 10X Genomics Inc., Agilent Technologies Inc., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Complete Genomics Inc., Dante Labs Inc., Element Biosciences Inc., Eurofins Genomics LLC, F. Hoffmann La Roche Ltd., GeneDx LLC, GENEWIZ Inc., Helix OpCo LLC, Illumina Inc., Macrogen Inc., Oxford Nanopore Technologies, Pacific Biosciences Inc., QIAGEN N.V., Tempus AI Inc., Thermo Fisher Scientific Inc., Ultima Genomics Inc.. Also, the global dna sequencing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Solution
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global DNA Sequencing Market 2020 - 2024
  • Historic Market Size - Data Table on Global DNA Sequencing Market 2020 - 2024 ($ million)
• 5.2 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.3 Solution segment analysis 2020 - 2024
  • Historic Market Size - Solution Segment 2020 - 2024 ($ million)
• 5.4 Technology segment analysis 2020 - 2024
  • Historic Market Size - Technology Segment 2020 - 2024 ($ million)
• 5.5 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.6 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.7 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global DNA Sequencing Market
• 6.2 Impact of Geopolitical Conflict on Global DNA Sequencing Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by End-user

• 8.1 Market segments
• 8.2 Comparison by End-user
• 8.3 Hospitals and clinics - Market size and forecast 2025-2030
• 8.4 Pharmaceutical and biotechnology companies - Market size and forecast 2025-2030
• 8.5 Academic research - Market size and forecast 2025-2030
• 8.6 Clinical research - Market size and forecast 2025-2030
• 8.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

9 Market Segmentation by Solution

• 9.1 Market segments
• 9.2 Comparison by Solution
• 9.3 Product - Market size and forecast 2025-2030
• 9.4 Services - Market size and forecast 2025-2030
• 9.5 Market opportunity by Solution
  • Market opportunity by Solution ($ million)

10 Market Segmentation by Technology

• 10.1 Market segments
• 10.2 Comparison by Technology
• 10.3 Next generation sequencing - Market size and forecast 2025-2030
• 10.4 Sanger sequencing - Market size and forecast 2025-2030
• 10.5 Third generation sequencing - Market size and forecast 2025-2030
• 10.6 Others - Market size and forecast 2025-2030
• 10.7 Market opportunity by Technology
  • Market opportunity by Technology ($ million)

11 Market Segmentation by Application

• 11.1 Market segments
• 11.2 Comparison by Application
• 11.3 Research - Market size and forecast 2025-2030
• 11.4 Genomics - Market size and forecast 2025-2030
• 11.5 Diagnostics - Market size and forecast 2025-2030
• 11.6 Medicine - Market size and forecast 2025-2030
• 11.7 Market opportunity by Application
  • Market opportunity by Application ($ million)

12 Customer Landscape

• 12.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

13 Geographic Landscape

• 13.1 Geographic segmentation
• 13.2 Geographic comparison
• 13.3 North America - Market size and forecast 2025-2030
  • 13.3.1 US - Market size and forecast 2025-2030
  • 13.3.2 Canada - Market size and forecast 2025-2030
  • 13.3.3 Mexico - Market size and forecast 2025-2030
• 13.4 Europe - Market size and forecast 2025-2030
  • 13.4.1 UK - Market size and forecast 2025-2030
  • 13.4.2 Germany - Market size and forecast 2025-2030
  • 13.4.3 France - Market size and forecast 2025-2030
  • 13.4.4 Italy - Market size and forecast 2025-2030
  • 13.4.5 Spain - Market size and forecast 2025-2030
  • 13.4.6 The Netherlands - Market size and forecast 2025-2030
• 13.5 Asia - Market size and forecast 2025-2030
  • 13.5.1 Japan - Market size and forecast 2025-2030
  • 13.5.2 China - Market size and forecast 2025-2030
  • 13.5.3 India - Market size and forecast 2025-2030
  • 13.5.4 South Korea - Market size and forecast 2025-2030
  • 13.5.5 Thailand - Market size and forecast 2025-2030
  • 13.5.6 Singapore - Market size and forecast 2025-2030
• 13.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 13.6.1 Brazil - Market size and forecast 2025-2030
  • 13.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 13.6.3 UAE - Market size and forecast 2025-2030
  • 13.6.4 Turkey - Market size and forecast 2025-2030
  • 13.6.5 Argentina - Market size and forecast 2025-2030
  • 13.6.6 Colombia - Market size and forecast 2025-2030
  • 13.6.7 South Africa - Market size and forecast 2025-2030
  • 13.6.8 Israel - Market size and forecast 2025-2030
• 13.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

14 Drivers, Challenges, and Opportunity

• 14.1 Market drivers
  • Advancements in precision medicine and targeted oncology
  • Technological innovations associated DNA sequencing
  • Increasing applications in infectious disease surveillance and public health
• 14.2 Market challenges
  • High initial investment and operational costs
  • Limited standardization and interoperability of technologies and data
  • Data management and analytical complexity in genomics
• 14.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 14.4 Market opportunities
  • Integration of AI and ML for drug discovery
  • Advancements in spatial biology and single-cell transcriptomics
  • Expansion of long-read sequencing in clinical and regulatory settings

15 Competitive Landscape

• 15.1 Overview
• 15.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 15.3 Landscape disruption
  • Overview on factors of disruption
• 15.4 Industry risks
  • Impact of key risks on business

16 Competitive Analysis

• 16.1 Companies profiled
  • Companies covered
• 16.2 Company ranking index
  • Company ranking index
• 16.3 Market positioning of companies
  • Matrix on companies position and classification
• 16.4 10X Genomics Inc.
  • 10X Genomics Inc. - Overview
  • 10X Genomics Inc. - Product / Service
  • 10X Genomics Inc. - Key offerings
  • SWOT
• 16.5 Agilent Technologies Inc.
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key news
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Segment focus
  • SWOT
• 16.6 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
  • SWOT
• 16.7 Dante Labs Inc.
  • Dante Labs Inc. - Overview
  • Dante Labs Inc. - Product / Service
  • Dante Labs Inc. - Key offerings
  • SWOT
• 16.8 Element Biosciences Inc.
  • Element Biosciences Inc. - Overview
  • Element Biosciences Inc. - Product / Service
  • Element Biosciences Inc. - Key offerings
  • SWOT
• 16.9 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 16.10 GeneDx LLC
  • GeneDx LLC - Overview
  • GeneDx LLC - Product / Service
  • GeneDx LLC - Key offerings
  • SWOT
• 16.11 GENEWIZ Inc.
  • GENEWIZ Inc. - Overview
  • GENEWIZ Inc. - Product / Service
  • GENEWIZ Inc. - Key offerings
  • SWOT
• 16.12 Helix OpCo LLC
  • Helix OpCo LLC - Overview
  • Helix OpCo LLC - Product / Service
  • Helix OpCo LLC - Key offerings
  • SWOT
• 16.13 Illumina Inc.
  • Illumina Inc. - Overview
  • Illumina Inc. - Business segments
  • Illumina Inc. - Key news
  • Illumina Inc. - Key offerings
  • Illumina Inc. - Segment focus
  • SWOT
• 16.14 Oxford Nanopore Technologies
  • Oxford Nanopore Technologies - Overview
  • Oxford Nanopore Technologies - Product / Service
  • Oxford Nanopore Technologies - Key offerings
  • SWOT
• 16.15 QIAGEN N.V.
  • QIAGEN N.V. - Overview
  • QIAGEN N.V. - Product / Service
  • QIAGEN N.V. - Key offerings
  • SWOT
• 16.16 Tempus AI Inc.
  • Tempus AI Inc. - Overview
  • Tempus AI Inc. - Product / Service
  • Tempus AI Inc. - Key offerings
  • SWOT
• 16.17 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT
• 16.18 Ultima Genomics Inc.
  • Ultima Genomics Inc. - Overview
  • Ultima Genomics Inc. - Product / Service
  • Ultima Genomics Inc. - Key offerings
  • SWOT

17 Appendix

• 17.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 17.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 17.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 17.4 Research methodology
  • Research methodology
• 17.5 Data procurement
  • Information sources
• 17.6 Data validation
  • Data validation
• 17.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 17.8 Data synthesis
  • Data synthesis
• 17.9 360 degree market analysis
  • 360 degree market analysis
• 17.10 List of abbreviations
  • List of abbreviations